Cargando…
Cryptotanshinone alleviates polycystic ovary syndrome in rats by regulating the HMGB1/TLR4/NF-κB signaling pathway
Cryptotanshinone (CRY) has been demonstrated to reverse reproductive disorders. However, whether CRY is effective in the treatment of polycystic ovary syndrome (PCOS) remains unknown. The aim of the present study was to evaluate the therapeutic potential of CRY in PCOS. A rat model of PCOS was estab...
Autores principales: | Yang, Yijiao, Yang, Ling, Qi, Cao, Hu, Guohua, Wang, Longhui, Sun, Zhuojun, Ni, Xiaorong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533513/ https://www.ncbi.nlm.nih.gov/pubmed/32901834 http://dx.doi.org/10.3892/mmr.2020.11469 |
Ejemplares similares
-
Soy isoflavones alleviate polycystic ovary syndrome in rats by regulating NF- κB signaling pathway
por: Ma, Xiaohong, et al.
Publicado: (2021) -
Tanshinone for polycystic ovary syndrome: A protocol of systematic review and meta-analysis
por: Yang, Yijiao, et al.
Publicado: (2021) -
CTBP1-AS upregulation is associated with polycystic ovary syndrome and can be effectively downregulated by cryptotanshinone
por: Wen, Mingxiao, et al.
Publicado: (2022) -
Engeletin alleviates cerebral ischemia reperfusion‐induced neuroinflammation via the HMGB1/TLR4/NF‐κB network
por: Xu, Yangyang, et al.
Publicado: (2023) -
rhHMGB1 drives osteoblast migration in a TLR2/TLR4- and NF-κB-dependent manner
por: Li, Ming-Jing, et al.
Publicado: (2016)